FDA approves GSK's bird flu vaccine for national stockpile

The Food and Drug Administration said on Friday it has approved a vaccine made by GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic. The vaccine will be added to the national stockpile and will not be available for commercial use, the FDA said. The vaccine does not have a trade name in the United States. It is the first H5N1 vaccine approved in the United States to contain an adjuvant, or booster, that turbo-charges the body's immune response to the vaccine.

via Health News Headlines - Yahoo! News http://news.yahoo.com/fda-approves-gsks-bird-flu-vaccine-national-stockpile-151522672--finance.html